Colorado BioScience Association (CBSA) Digital Press Kit Colorado BioScience Association is a not-for-profit corporation providing services and support for Colorado’s growing biosciences industry. Colorado is carrying out an aggressive plan to grow the state’s bioscience industry into one of the country’s premier bioscience clusters. CBSA currently enjoys the support of more than 350 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The association’s main office is located at 216 16th Street, suite 850, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and the Fort Collins Technology Incubator.  You can learn more about CBSA at http://www.cobioscience.com. Further, if you're needing high resolution jpgs, contact Maggie Holben at maggie@absolutelypr.com. Download CBSA logo jpg - 999 x 463 Download CBSA logo jpg - 240 x 111 Links to CBSA's recent news releases: Colorado BioScience Association Celebrates 2011 Industry Standouts The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its 9th Annual Awards Dinner at the Downtown Denver Embassy Suites. The CBSA's Annual Awards program showcases the significant achievements in the state's bioscience industry throughout the year. - December 09, 2011 Photo Exhibit by Colorado BioScience Association Keynote Speaker Rick Guidotti Begins Friday, November 18, at VSA Colorado/Access Gallery, Santa Fe Arts District Photos by Colorado BioScience Association (CBSA) Awards Dinner Keynote Presenter Rick Guidotti will be on display for a month, beginning November 18, at Denver's CSA Colorado/Access Gallery in the Santa Fe Arts District. Guidotti, award winning fashion photographer, is known worldwide for his dynamic images and important message about genetic difference. - November 14, 2011 Colorado BioScience Association Launches Internship Program with Support of 11 Area Employers and Universities The Education Committee of the Colorado BioScience Association (CBSA) is launching its new Internship Program with the support of 11 Founding Employers and the major universities in the state. Intern recruitment begins immediately through early spring 2012, with the first interns expected to be placed in positions by summer 2012. - November 10, 2011 Colorado BioScience Association Hosts World Renowned Photographer Rick Guidotti for Keynote Presentation at Industry Awards Celebration in Denver Registration is now open for the Colorado BioScience Association (CBSA) Annual Awards Dinner, featuring Keynote Presenter Rick Guidotti, world renowned photographer and co-founder of New York-based Positive Exposure. The CBSA awards event is Thursday, December 8, at the Embassy Suites in Downtown Denver. - October 27, 2011 Innovative Thought Leaders Address the 2011 Rocky Mountain Life Science Investor Conference in Denver The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will host several keynote speakers who are shaping the future of bioscience. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO. - September 21, 2011 2011 Rocky Mountain Life Science Investor and Partnering Conference Attracts More Than 30 International Investors to Denver September 21-22 More than 30 leading biotech, device, diagnostic and pharma investors from across the country and world will be coming to Denver to create the newest deals and shape the future landscape of the life science industry. The Rocky Mountain Life Science Investor & Partnering Conference (RMLIPC) is September 21-22 at the Brown Palace Hotel. - September 07, 2011 Colorado BioScience Association Serves as Catalyst in Assembling CEO Rountable Discussion for Senator Michael Bennet and FDA Commissioner Margaret Hamburg The Colorado BioScience Association (CBSA) brought more than 35 industry CEOs together today to dialogue with Senator Michael Bennet and U.S. FDA Commissioner Margaret Hamburg at the Anschutz Medical Campus in Aurora. At Senator Bennet's request, CBSA designed today's session to share the bioscience industry's specific and unique needs in bringing innovative drugs and devices to market under current, often constraining, market conditions. - August 22, 2011 Thirty Regional Companies Selected to Present at the 2011 Rocky Mountain Life Science Investor Conference in Denver The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO. - August 10, 2011 Colorado BioScience Association Showcases Colorado's Bioscience Industry at BIO 2011 Conference in Washington DC, June 27-30  Colorado BioScience Association (CBSA) will head the Colorado Pavilion at the Biotechnology Industry Organization’s (BIO) International Convention in Washington DC, June 27-30. The Colorado Pavilion, located in booth # 2107 of the Exhibit Hall area, includes a number of companies and partners helping to grow the bioscience industry in the state. - June 29, 2011 Colorado BioScience Association Applauds Boettcher Foundation on Announcing the Second Class of Boettcher Investigators in the Webb-Waring Biomedical Research Program The Colorado BioScience Association applauds Boettcher Foundation on the announcement of its 2011 class of Boettcher Investigators in the Webb-Waring Biomedical Research Program. The program, launched last year, provides for the discovery of new knowledge that improves human health through the investment in and advancement of early-career scientists. - June 01, 2011 Colorado Bioscience Association Commends Governor John Hickenlooper's Signing of The Innovation Reinvestment Act Senate Bill 47, Bolstering Fuds for the State's Bioscience Discovery Evaluation Grant Program Colorado Governor John Hickenlooper signed The Innovation Reinvestment Act, Senate Bill 47, into law at ceremonies held May 26th at the Denver Museum of Nature and Science. Initiated by the Colorado BioScience Association and Colorado Cleantech Industry Association, Senate Bill 47 provides up to $2 million annually to each industry, creating new companies and stimulating job growth based on promising discoveries made at the state’s major research institutions. - May 27, 2011
Colorado BioScience Association Names Steve Orndorff Board Chair and Appoints Four New Board Members at 2011 Annual All-Member Meeting Colorado BioScience Association (CBSA) announces Steve Orndorff, President & CEO of Ariel pharmaceuticals, as the new chairperson of the board of directors. Orndorff assumes chairperson responsibilities from Rick Jory, Sandhill Scientific, Inc. In other action, four new members were named to the CBSA board of directors. - April 08, 2011 Colorado BioScience Association Launches 2011 Symposium Series With "Biotech & Pharma" Session February 17, Featuring CEOs from Array BioPharma, GlobeImmune, Ariel Pharmacueticals and Aegis Analytical Corp. The Colorado BioScience Association (CBSA) is launching its 2011 Symposium Series Thursday, February 17, with the session, "Biotech & Pharma," 1-7 p.m., at the Grand Hyatt Denver, 1750 Welton Street. - February 15, 2011 Colorado's Bioscience Discovery Evaluation Grant Program Creates 598 New Jobs in the State, with Payroll Exceeding $44 millionThe Colorado BioScience Association (CBSA) and The Colorado Office of Economic Development and International Trade (OEDIT) have jointly released results of the Bioscience Discovery Evaluation Grant Program (BDEGP) at the CBSA's Third Annual "Bioscience Day at the Capitol" event. The BDEGP was created by the Colorado General Assembly in 2006 to grow the bioscience industry in the state. - February 02, 2011 2010: Colorado’s Bioscience Industry Awarded Over $23 Million in Funding from Federal Qualifying Therapeutic Discovery Project Grant and Tax Credit Program According to the Colorado BioScience Association (CBSA), Colorado’s bioscience industry received more than $23 million for 102 different projects in the Qualifying Therapeutic Discovery Project (QTDP) program, per data posted online Monday by the Internal Revenue Service (IRS), in conjunction with the Department of Health and Human Services (HHS). Colorado ranks in the top ten of states applying for credits and grants under the new program. - November 06, 2010 The Colorado BioScience Association and 650+ Partners Oppose Amendments 60 and 61 & Proposition 101 The Colorado BioScience Association along with over 650 partners are opposed to three ballot measures facing Colorado this election – Amendment 60, Amendment 61 and Proposition 101. These three measures - also known as the 'ugly three' - are referred to as tax breaks, but will have a devastating impact on Colorado and the companies located in the state for years to come. - October 27, 2010 Colorado BioScience Association and Two of the State’s Economic Development Entities, Tout Colorado’s Strengths at AdvaMed 2010 Representatives from the Colorado BioScience Association, Colorado Office of Economic Development and International Trade and Metro Denver Economic Development Corporation will showcase Colorado’s medical device and diagnostics sectors during the 2010 AdvaMed: The MedTech Conference in Washington D.C., October 18-20. - October 20, 2010 Colorado BioScience Association Announces Winners of Its 2010 Awards, Honoring The Best of Colorado's Bioscience Industry The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its 2010 Annual Awards Dinner held in conjunction with the BioWest Conference & Expo at the Denver Grand Hyatt. The Annual Awards Dinner gives CBSA the ability to showcase companies and individuals that have had an outstanding year and to celebrate the industry as a whole. - October 11, 2010 Sharklet Technologies Wins Dorsey & Whitney Venture Showcase Award, Presented at 2010 BioWest Conference & Expo Sharklet Technologies, Inc., has won the Dorsey & Whitney Venture Showcase Award at the 2010 BioWest Conference & Expo in Denver. The announcement is made by Holli Baumunk, President & CEO of the Colorado BioScience Association (CBSA), who says the $7,500 Venture Showcase award was provided by the Dorsey & Whitney law firm and announced at the 2010 CBSA Awards Dinner. - October 02, 2010 Colorado BioScience Association Announces Winners Of Its 2010 Awards, Honoring The Best of Colorado's Bioscience Industry The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its 2010 Annual Awards Dinner held in conjunction with the BioWest Conference & Expo at the Denver Grand Hyatt. The Annual Awards Dinner gives CBSA the ability to showcase companies and individuals that have had an outstanding year and to celebrate the industry as a whole. - September 30, 2010 2010 BioWest Conference & Expo to Showcase 40+ New Technologies, Products and Services More than 40 exhibitors will be showcasing new technology, products and services for 500+ attendees at the 2010 BioWest Conference & Expo, September 29 and 30, at the Grand Hyatt Denver, 1750 Welton. BioWest, in its eighth year, is the Rocky Mountain region’s preferred venue for visiting and learning about the bioscience industry. - September 23, 2010 Four Finalists Selected for BioWest 2010 Venture Showcase Competition, Presenting Life-Changing Technologies Cutting-edge development of a universal influenza vaccine, creation of an innovative hybridCpeptide manufacturing process, groundbreaking wastewater treatment through a new algae production system, and a revolutionary nontoxic surface treatment to control the growth of bacteria in hospitals, comprise the four finalists in this year’s BioWest Venture Showcase competition. - September 13, 2010 Colorado's Emmy® Award Winning Heroine Dr. Temple Grandin Keynotes CBSA Awards Dinner at 2010 BioWest Conference & Expo General registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference & Expo, BioWest 2010. More than 700 participants are expected at this year’s event, September 29-30, at the Grand Hyatt (1750 Welton) in Denver. Headlining the Annual Awards Dinner during the 2010 BioWest Conference is Dr. Temple Grandin, noted author, speaker, scientist and autism expert who leads an impressive line up of national and international industry speakers and panelists. - September 07, 2010 Colorado BioScience Association Seeks Region’s Top Innovators for Venture Showcase Competition at 2010 BioWest Conference & Expo The organizers of the annual BioWest Conference & Expo are again looking for the best bioscience start-ups in the region as candidates for this year's $7,500 Dorsey & Whitney Venture Showcase Award. Four companies will be chosen to present at the showcase on Wednesday, September 29, 2010, and will be judged by a panel of venture capitalists. Deadline for entry is Friday, August 20. - August 04, 2010 Colorado BioScience Association Commends Boettcher Foundation on Historic Launch of Webb-Waring Biomedical Research Program & Inaugural Class of 'Boettcher Investigators' Colorado BioScience Association commends Boettcher Foundation on launching the new Webb-Waring Biomedical Research Program and its 2010 (Inaugural) Class of Boettcher Investigators. This new grant program will ensure that the Webb-Waring legacy lives on both through the discovery of new knowledge that improves human health and through the investment in and advancement of early-career scientists. - July 01, 2010 Economic Development Executive Holli Baumunk Named President & CEO of the Colorado BioScience Association Effective July 12 Holli Baumunk, Vice President of the Metro Denver Economic Development Corporation for the past seven years, has been named President & CEO of the Colorado BioScience Association (CBSA) July 12. The announcement is made by Rick Jory, CBSA Board Chairperson, who says Baumunk was unanimously recommended... - June 24, 2010 Governor Bill Ritter Jr. Signs Executive Orders Initiated by Colorado BioScience Association (CBSA) to Ensure Continued Investment in Life Sciences Governor Bill Ritter Jr. signed two executive orders initiated by the Colorado BioScience Association (CBSA) today, calling for an online “Investment Opportunity Index” to classify opportunities for capital investment within the bioscience and cleantech industries, as well as a quarterly Roundtable on Venture Capital with the Governor – focusing on bioscience, renewable energy and aerospace. - May 28, 2010 Colorado BioScience Association Showcases Colorado's Bioscience Industry at BIO 2010 Conference in Chicago, May 3-6 Colorado’s life sciences community will be heavily represented at the Biotechnology Industry Organization’s (BIO) International Convention, May 3-6 in Chicago. The Colorado BioScience Association (CBSA) will play a lead role in showcasing companies and partners helping to grow the bioscience industry in the state at The Colorado Pavilion, located in booth #1426 of the Exhibit Hall area. - May 05, 2010 Colorado BioScience Association Hosts Second Annual Career and Resource Fair, April 28, at the Jefferson County Fairgrounds The Colorado BioScience Association (CBSA) hosts its second annual Career and Resource Fair on Wednesday, April 28, from 1 to 4 p.m. at the Jefferson County Fairgrounds. The event will bring students and job seekers - looking to learn more about careers in Colorado's bioscience industry - together with some of the state’s most dynamic life sciences companies and education organizations. - April 25, 2010 Colorado BioScience Association Announces 2010 Sponsors and Appoints Nine New Board Members The Colorado BioScience Association (CBSA) announced 2010 association sponsors and welcomed nine new directors at its 2010 Annual All-Member Meeting held at the Colorado National Golf Club facilities in Erie, CO. The agenda also included presentations about the newly formed Colorado Institute for Drug, Device and Diagnostic Development (CID4) and Colorado Center for Drug Discovery (C2D2). - April 21, 2010 Colorado’s Bioscience Industry Leaders and Legislators Focus on 2010 Initiatives at the Annual CBSA ‘Bioscience Day at the Capitol’ The second annual “Bioscience Day at the Capitol,” being held Wednesday, January 27, 7:30 – 10 a.m., will allow bioscience industry leaders and state legislators to discuss the industry and thoughts on the year ahead. The Colorado BioScience Association (CBSA) will also present its legislative initiatives for 2010 to the group. - January 25, 2010 Colorado BioScience Association Moves Offices with Two Other Associations to Columbine Place at 216 16th Street, Suite 850, Denver The Colorado BioScience Association (CBSA) along with the Colorado Association for Manufacturing and Technology (CAMT) and the Colorado Software and Internet Association (CSIA) have moved together to a new office located in Downtown Denver. The announcement is made by John Collar, President and CEO of... - November 27, 2009 Colorado Bioscience Association Recognizes the Best of Colorado’s Bioscience Industry The Colorado BioScience Association (CBSA) has released the winners of the 2009 Awards Program. Official presentation of the awards occurs Tuesday, November 10, 6:00 to 8:30 p.m., at the CBSA’s Annual Awards Dinner. Mountaineer Eric Alexander will serve as the keynote speaker for this event as the Colorado Bioscience Association celebrates its sixth anniversary. - November 06, 2009 Expo at BioWest 2009 Showcases New Technology, Products and Services for the Region’s Robust Bioscience Industry More than 40 exhibitors will be showcasing new technology, products and services for 700+ attendees at the 2009 BioWest Conference and Expo, November 10, at the Grand Hyatt Denver, 1750 Welton. BioWest, in its seventh year, is the Rocky Mountain region’s preferred venue for visiting and learning about the bioscience industry. - October 31, 2009 BioWest 2009 Registration Opens, Rolling Out a Stellar Lineup of National Speakers Peter Sims, co-author of best selling business book “True North” and the forthcoming book “Little Bets” will provide the keynote for the 2009 BioWest Conference and Expo. In addition to Sims, nationally acclaimed speakers Ginger Graham, former CEO of Amylin Pharmaceuticals, and Eric Alexander - skier, climber, and mountaineer - will address the BioWest audience during the November 10th event at the Grand Hyatt Denver. - October 22, 2009
Click here to link to the full news release archive Colorado Competes: A Report from Coloradoans for an Innovation Economy - June 24, 2011 Steve Orndorff Remarks - Signing of Colorado Senate Bill 47 - May 26, 2011 Holli Baumunk Interview RE: CBSA's 2011 Symposium Series Launch - Business For Breakfast Feb 15, 2011 Holli Baumunk Interview - Business For Breakfast Jan 27, 2011 CBSA was featured in the Spring 2010 European Life Science Journal - Colorado's Bioscience Industry Boasts Strong Infrastructure CBSA was featured in the Fall 2009 European Life Science Journal - Rocky Mountain Life Science Investor Conference Debuts in the States CBSA was featured in the Spring 2009 -- BIO issue -- of the European Life Science Journal - Bioscience is no Longer an Emerging Industry in Colorado CBSA was featured in the Winter 2009 European Life Science Journal - Good Conditions Fuel Colorado's Bioscience Industry	Link to the 2011-12 Bioscience Colorado Magazine Boettcher Investigators: One-sheet Overview The Webb-Waring Biomedical Research Program: Executive Summary The Webb-Waring Biomedical Research Program: Program Overview The Webb-Waring Family Legacy iStudentAdvisor - the Science of Biotechnology in Colorado
About Steve Orndorff, PhD, CBSA Board Chair Dr. Orndorff, a serial entrepreneur with 30 years experience in the biotechnology industry, leads Ariel Pharmaceuticals, a startup specialty pharmaceutical company focused on orphan diseases and acute medical conditions of neurological origin. He is also the former founder, President and CEO of Accera, Inc. and President and CEO of Univera Pharmaceuticals, Inc., a drug discovery company focused on diseases of inflammation and the immune response. During his career, Dr. Orndorff has had responsibility in a broad array of disciplines such as basic research, manufacturing, product development and business development at various biotechnology companies including Genex Corporation, NutraSweet, Inc. and ZeaGen, Inc. He is a past President of the Society for Industrial Microbiology and a founding board member of the CBSA. He received a Bachelor’s Degree in Biology from Virginia Tech and a Ph.D. in microbiology from University of Maryland. Click here to link to read about the rest of the CBSA Board of Directors. Media Contact:  Maggie Chamberlin Holben, 303-984-9801, maggie@absolutelypr.com
1) News Feed Blog on the Google Blogger site. You can subscribe to receive news updates when posted: http://coloradobio.blogspot.com 2) Twitter: http://twitter.com/cobioscience 3) LinkedIn: http://www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro 4) Facebook Fan Page: http://www.facebook.com/ColoradoBioScienceAssociation  5) YouTube Channel: http://www.youtube.com/COBioscience

CPR - Venture Showcase 2010

CPR Venture Showcase 2008 - Part One

CPR Venture Showcase 2008 - Part Two

Jan 2011 Focus Newsletter

RMLIPC 2011 - Fitz Cos Selected

From Denver: Surgeons successfully implant ValveXchange® two-part heart valve system

The Future of Heart Valve Therapy

Strategic Value Creation

MDMA Presentation

Anselmo Presentation